|
|
|
| home > white papers > Generating Scientific Insights by Deep Collaboration - Bridging the Big Data Divide Between Clinical and Research - BioFortis |
|
|
 WHITE PAPERS |
|
|
BioFortis
|
|
Generating Scientific Insights by Deep Collaboration - Bridging the Big Data Divide Between Clinical and Research
|
|
Translational research, biomarker discovery, clinical studies and even biobanking have become increasingly data intensive. However, generating scientific insights from such disparate “big” data sources across multiple domains is a challenge for both researchers and the informaticians that support them. Download our Deep Collaboration Whitepaper and and learn how to bridge the clinical and research divide to better explore your biomarker based trials.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio
BioIVT,
a leading provider of research models and services for drug development, today
announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and
its comprehensive portfolio of transporter assays, multi-transporter models,
transporter systems biology, and molecular transport research solutions.
More info >> |
|
 |
White Papers |
 |
|
Advanced BioDesign Outlines Solutions
Advanced BioDesign
Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, clients may develop and produce antibodies according to customers' specific needs. The company offers: real support and advice from a dedicated team all along your project; large and modern SPF animal facility; ethical treatment of animals. The evaluation of a project is free-of-charge and with no obligation. Dedicated project managers will work with clients from the beginning to the end of a custom antibody project to ensure the highest level of quality and service.
More info >> |
|
 |
Industry Events |
 |
BioPharm America 2018
5-6 September 2018, Hynes Convention Center
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
More info >> |
|
|
|
